Erratum to Myostatin Induces Degradation of Sarcomeric Proteins through a Smad3 Signaling Mechanism during Skeletal Muscle Wasting (Mol Endocrinol, 2011, 25, (1936-1946) 10.1210/me.2011-1124);Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting

Molecular Endocrinology

Volumn 25, Issue 11, 2011, Pages 1936-1949

  Lokireddy, Sudarsanareddy ^a   McFarlane, Craig ^b   Ge, Xiaojia ^a   Zhang, Huoming ^a   Sze, Siu Kwan ^a   Sharma, Mridula ^c   Kambadur, Ravi ^a,b  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b AGENCY FOR SCIENCE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ATROGIN 1; MUSCLE PROTEIN; MUSCLE RING FINGER 1 PROTEIN; MYOSIN HEAVY CHAIN; MYOSIN LIGHT CHAIN; MYOSTATIN; PROTEASOME; SMAD3 PROTEIN; TRANSCRIPTION FACTOR FKHR; UBIQUITIN PROTEIN LIGASE E3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENE SILENCING; MOUSE; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SARCOMERE; SKELETAL MUSCLE; UBIQUITINATION;

EID: 80054966387     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2014-1357     Document Type: Erratum

References (46)

1. Tisdale MJ 2009 Mechanisms of cancer cachexia. Physiol Rev 89: 381-410
2. Evans WJ 2010 Skeletal muscle loss: cachexia, sarcopenia, and inactivity. Am J Clin Nutr 91:1123S-1127S
3. Csibi A, Leibovitch MP, Cornille K, Tintignac LA, Leibovitch SA 2009 MAFbx/Atrogin-1 controls the activity of the initiation factor eIF3-f in skeletal muscle atrophy by targeting multiple C-terminal lysines. J Biol Chem 284:4413-4421
4. Csibi A, Tintignac LA, Leibovitch MP, Leibovitch SA 2008 eIF3-f function in skeletal muscles: to stand at the crossroads of atrophy and hypertrophy. Cell Cycle 7:1698-1701
5. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Va-lenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ 2001 Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294:1704-1708
6. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL 2001 Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 98:14440-14445
7. Clarke BA, Drujan D, Willis MS, Murphy LO, Corpina RA, Burova E, Rakhilin SV, Stitt TN, Patterson C, Latres E, Glass DJ 2007 The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexam-ethasone-treated skeletal muscle. Cell Metab 6:376-385
8. Cohen S, Brault JJ, Gygi SP, Glass DJ, Valenzuela DM, Gartner C, Latres E, Goldberg AL 2009 During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. J Cell Biol 185:1083-1095
9. Krawiec BJ, Frost RA, Vary TC, Jefferson LS, Lang CH 2005 Hindlimb casting decreases muscle mass in part by proteasome-dependent proteolysis but independent of protein synthesis. Am J Physiol Endocrinol Metab 289:E969-E980
10. Schakman O, Gilson H, Kalista S, Thissen JP 2009 Mechanisms of muscle atrophy induced by glucocorticoids. Horm Res 72(Suppl 1):36-41
11. Testelmans D, Crul T, Maes K, Agten A, Crombach M, Decramer M, Gayan-Ramirez G 2010 Atrophy and hypertrophy signaling in the diaphragm of patients with COPD. Eur Respir J 35:549-556
12. Chen Y, Cao L, Ye J, Zhu D 2009 Upregulation of myostatin gene expression in streptozotocin-induced type 1 diabetes mice is attenuated by insulin. Biochem Biophys Res Commun 388:112-116
13. Leger B, Senese R, Al-Khodairy AW, Deriaz O, Gobelet C, Giaco-bino JP, Russell AP 2009 Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3/3 and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients. Muscle Nerve 40:69-78
14. Mittal A, Bhatnagar S, Kumar A, Lach-Trifilieff E, Wauters S, Li H, Makonchuk DY, Glass DJ, Kumar A 2010 The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice. J Cell Biol 188:833-849
15. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL 2004 Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117:399-412
16. Latres E, Amini AR, Amini AA, Griffiths J, Martin FJ, Wei Y, Lin HC, Yancopoulos GD, Glass DJ 2005 Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phospha-tidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/ Akt/mTOR) pathway. J Biol Chem 280:2737-2744
17. Xu Q, Wu Z 2000 The insulin-like growth factor-phosphatidyli-nositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-de-rived RD cells. J Biol Chem 275:36750-36757
18. McPherron AC, Lee SJ 1997 Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci USA 94:12457-12461
19. Kambadur R, Sharma M, Smith TP, Bass JJ 1997 Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmon-tese cattle. Genome Res 7:910-916
20. Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, Braun T, Tobin JF, Lee SJ 2004 Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350:2682-2688
21. McPherron AC, Lawler AM, Lee SJ 1997 Regulation of skeletal muscle mass in mice by a new TGF-/3 superfamily member. Nature 387:83-90
22. Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, McPherron AC, Wolfman NM, Lee SJ 2002 Induction of cachexia in mice by systemically administered myostatin. Science 296:1486-1488
23. Durieux AC, Amirouche A, Banzet S, Koulmann N, Bonnefoy R, Pasdeloup M, Mouret C, Bigard X, Peinnequin A, Freyssenet D 2007 Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression. Endocrinology 148:3140-3147
24. McFarlane C, Plummer E, Thomas M, Hennebry A, Ashby M, Ling N, Smith H, Sharma M, Kambadur R 2006 Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-«B-independent, FoxO1-dependent mechanism. J Cell Physiol 209:501-514
25. Trendelenburg AU, Meyer A, Rohner D, Boyle J, Hatakeyama S, Glass DJ 2009 Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. Am J Physiol Cell Physiol 296:C1258-C1270
26. Zhou X, Wang JL, Lu J, Song Y, Kwak KS, Jiao Q, Rosenfeld R, Chen Q, Boone T, Simonet WS, Lacey DL, Goldberg AL, Han HQ 2010 Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142:531-543
27. Lee SJ, Reed LA, Davies MV, Girgenrath S, Goad ME, Tomkinson KN, Wright JF, Barker C, Ehrmantraut G, Holmstrom J, Trowell B, Gertz B, Jiang MS, Sebald SM, Matzuk M, Li E, Liang LF, Quattle-baum E, Stotish RL, Wolfman NM 2005 Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc Natl Acad Sci USA 102:18117-18122
28. Walsh S, Metter EJ, Ferrucci L, Roth SM 2007 Activin-type II receptor B (ACVR2B) and follistatin haplotype associations with muscle mass and strength in humans. J Appl Physiol 102:2142-2148
29. Amthor H, Nicholas G, McKinnell I, Kemp CF, Sharma M, Kambadur R, Patel K 2004 Follistatin complexes myostatin and antagonises myostatin-mediated inhibition of myogenesis. Dev Biol 270: 19-30
30. Tawa Jr NE, Odessey R, Goldberg AL 1997 Inhibitors of the pro-teasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J Clin Invest 100:197-203
31. Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, Kamba-dur R 2002 Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 277:49831-49840
32. Amirouche A, Durieux AC, Banzet S, Koulmann N, Bonnefoy R, Mouret C, Bigard X, Peinnequin A, Freyssenet D 2009 Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle. Endocrinology 150:286-294
33. McFarlane C, Sharma M, Kambadur R 2008 Myostatin is a pro-cachectic growth factor during postnatal myogenesis. Curr Opin Clin Nutr Metab Care 11:422-427
34. Lagirand-Cantaloube J, Offner N, Csibi A, Leibovitch MP, Baton-net-Pichon S, Tintignac LA, Segura CT, Leibovitch SA 2008 The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy. EMBO J 27:1266-1276
35. Lagirand-Cantaloube J, Cornille K, Csibi A, Batonnet-Pichon S, Leibovitch MP, Leibovitch SA 2009 Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo. PLoS One 4:e4973
36. Sartori R, Milan G, Patron M, Mammucari C, Blaauw B, Abraham R, Sandri M 2009 Smad2 and 3 transcription factors control muscle mass in adulthood. Am J Physiol Cell Physiol 296:C1248-C1257
37. Amthor H, Huang R, McKinnell I, Christ B, Kambadur R, Sharma M, Patel K 2002 The regulation and action of myostatin as a negative regulator of muscle development during avian embryogenesis. Dev Biol 251:241-257
38. Lee SJ, McPherron AC 2001 Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 98:9306-9311
39. Hill JJ, Davies MV, Pearson AA, Wang JH, Hewick RM, Wolfman NM, Qiu Y 2002 The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 277:40735-40741
40. McCroskery S, Thomas M, Maxwell L, Sharma M, Kambadur R 2003 Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 162:1135-1147
41. McFarlane C, Hennebry A, Thomas M, Plummer E, Ling N, Sharma M, Kambadur R 2008 Myostatin signals through Pax7 to regulate satellite cell self-renewal. Exp Cell Res 314:317-329
42. Tsai A, Carstens RP 2006 An optimized protocol for protein purification in cultured mammalian cells using a tandem affinity purification approach. Nat Protoc 1:2820-2827
43. Woodcock SA, Jones RC, Edmondson RD, Malliri A 2009 A modified tandem affinity purification technique identifies that 14-3-3 proteins interact with Tiam1, an interaction which controls Tiam1 stability. J Proteome Res 8:5629-5641
44. Burckstummer T, Bennett KL, Preradovic A, Schutze G, Hantschel O, Superti-Furga G, Bauch A 2006 An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells. Nat Methods 3:1013-1019
45. Driscoll J, Goldberg AL 1990 The proteasome (multicatalytic protease) is a component of the 1500-kDa proteolytic complex which degrades ubiquitin-conjugated proteins. J Biol Chem 265:4789-4792
46. Hershko A 1988 Ubiquitin-mediated protein degradation. J Biol Chem 263:15237-15240